Early Access

Back to MCK

MCKESSON CORP Cash & Equivalents 2007-2026 | MCK

Beta

What is cash & equivalents?

Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.

What is MCKESSON CORP's current cash & equivalents?

MCKESSON CORP (MCK) annual cash & equivalents for 2025 was $5.69B, a 24.18% increase from 2024. MCKESSON CORP cash & equivalents for the quarter ending December 31, 2025 was $2.96B.

What was MCKESSON CORP's cash & equivalents in 2024?

MCKESSON CORP annual cash & equivalents for 2024 was $4.58B, a 2.03% decline from 2023.

What was MCKESSON CORP's cash & equivalents in 2023?

MCKESSON CORP annual cash & equivalents for 2023 was $4.68B, a 32.45% increase from 2022.

What is MCKESSON CORP's 5-year cash & equivalents CAGR?

MCKESSON CORP cash & equivalents grew at a compound annual growth rate (CAGR) of 7.23% from FY2020 to FY2025, going from $4.01B to $5.69B over 5 years.

Cash & Equivalents History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR+7.2%
FY2020
$4.01B
→
FY2025
$5.69B
07080910111213141516171819202122232425
5 years selected
Cash & Equivalents History
PeriodValueChangeSource
FY2025$5.69B+24.2%10-K
FY2024$4.58B-2.0%10-K
FY2023$4.68B+32.4%10-K
FY2022$3.53B-43.7%10-K
FY2021$6.28B+56.4%10-K
FY2020$4.01B+34.7%10-K
FY2019$2.98B+11.6%10-K
FY2018$2.67B-4.0%10-K
FY2017$2.78B-31.3%10-K
FY2016$4.05B-24.2%10-K
FY2015$5.34B+27.4%10-K
FY2014$4.19B+70.7%10-K
FY2013$2.46B-22.0%10-K
FY2012$3.15B-12.8%10-K
FY2011$3.61B-3.2%10-K
FY2010$3.73B+76.9%10-K
FY2009$2.11B+54.8%10-K
FY2008$1.36B-30.3%10-K
FY2007$1.95B-10-K
Company: MCKESSON CORPTicker: MCKSector: HealthcareIndustry: Wholesale-Drugs, Proprietaries & Druggists' SundriesView company profile →